Statements (12)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Astellas_Pharma
|
| gptkbp:acquisitionYear |
2018
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:developedBy |
immunotherapies
|
| gptkbp:focus |
immuno-oncology
|
| gptkbp:founded |
2014
|
| https://www.w3.org/2000/01/rdf-schema#label |
Potenza Therapeutics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:location |
gptkb:Cambridge,_Massachusetts
|
| gptkbp:bfsParent |
gptkb:Astellas_Pharma_Inc.
|
| gptkbp:bfsLayer |
7
|